University of Pennsylvania

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Pennsylvania sits in the top decile of US sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count).

1,423 total trials 199 currently recruiting 982 completed early-phase tilt top decile by trial count

University of Pennsylvania: 1,423 sponsored US clinical trials, 199 recruiting.

University of Pennsylvania sponsors 1,423 registered US clinical trials on ClinicalTrials.gov, 199 of them currently recruiting, and 982 completed. 130 of these trials are in Phase 3-4 (later-stage) and 339 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 17 trials.

Top-decile sponsor footprint

University of Pennsylvania ranks in the top decile of sponsors by registered trial count (#15 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

1,423 total, page 2 of 29

RECRUITING Phase 1

CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy

NCT06973096

RECRUITING NA

Induction of Labor After Cesarean Using Foley Alone vs. Concurrent Foley and Oxytocin

NCT07006896

RECRUITING NA

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

NCT07048496

RECRUITING NA

Dental Implant Healing With TNF-Alpha Inhibitors

NCT06538870

RECRUITING Phase 4

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

NCT06665997

RECRUITING Phase 2

Combined Oral Contraceptive Pill and Resistance Starch

NCT06852365

RECRUITING NA

MOVE-HF MOtivating Physical Activity With BehaVioral Economics in Heart Failure With Preserved Ejection Fraction

NCT06670001

RECRUITING

Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.

NCT07125079

RECRUITING Phase 2

Effects Ketone Supplement and Alcohol on Brain Metabolism

NCT06815237

RECRUITING Early Phase 1

Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A

NCT06932809

RECRUITING Phase 2

Rapid Outpatient Low-dose Initiation of Buprenorphine for OUD With Fentanyl Use

NCT06379984

RECRUITING NA

Uterine Preservation in the Management of Placenta Accreta Spectrum Disorders

NCT06512181

RECRUITING NA

Doula Model of Care

NCT06915259

RECRUITING NA

Philly CEAL- DECIDE+ Adaptation

NCT06732102

RECRUITING NA

Randomized Clinical Trial of TUNE In 3.0: A Social/Emotional Program for Adults With Autism Spectrum Disorder

NCT06859918

RECRUITING Phase 1

Army-SPRING Army-Suicide Prevention Research

NCT06547008

RECRUITING NA

Antidepressant Adherence for Depressed Adults in Primary Care

NCT06496646

RECRUITING NA

Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression

NCT06877104

RECRUITING NA

Videos to Aid Decision Making for Fibroid Treatment

NCT07072364

RECRUITING NA

Traumatic Hemothorax Drainage and Daily Lavage: Pilot Study

NCT06937450

RECRUITING

Transitional Housing and HIV Health

NCT06829394

RECRUITING NA

Teaching Health Resilience in a Hospital Setting: A Peer-led Intervention

NCT06843213

RECRUITING

OsciPulse D-dimer Pilot Trial

NCT06477016

RECRUITING Phase 2

Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia

NCT06842745

RECRUITING NA

Communication Strategies to Increase HPV Vaccination Intention

NCT06784960

RECRUITING

Flu Infection at UPHS

NCT06807840

RECRUITING

Remote Sputum Collection in Cystic Fibrosis

NCT06950892

RECRUITING Phase 2

Topical Anti-Androgens in Pilonidal Sinus Disease

NCT06286397

RECRUITING

Variability in Analgesic Response to Ibuprofen

NCT06539741

RECRUITING Early Phase 1

Sodium Glucose Co-transporter (SGLT) Inhibitors in Nonobstructive Hypertrophic Cardiomyopathy

NCT06433050

RECRUITING

Nasal vs Oral Breathing in Drug Induced Sleep vs Natural Sleep

NCT06789770

RECRUITING

Diagnostic Utility of SGLT1/2 Inhibition to Facilitate Myocardial Glucose Suppression

NCT06510894

RECRUITING

Next-Generation Photon-Counting CT Technology: Development and Clinical Evaluation

NCT06691659

RECRUITING

Characterization and Natural History of Williams Syndrome and Other Chromosome 7q11.23 Variants

NCT06930417

RECRUITING NA

Supporting Evidence-based Responses to Emotional Needs in Emphysema

NCT06600126

RECRUITING Early Phase 1

Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease

NCT06212271

RECRUITING NA

Mechanical Insufflation in the Philadelphia Amyotrophic Lateral Sclerosis Cohort (MI-PALS) Study

NCT06119087

RECRUITING NA

Postpartum Care in the NICU (PeliCaN) Transitions

NCT06521398

RECRUITING Phase 2

Letrozole and Misoprostol for Early Pregnancy Loss Management

NCT06452719

RECRUITING Phase 2

PMT for MDRO Decolonization

NCT05632315

RECRUITING NA

Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)

NCT06438640

RECRUITING NA

Home-Based Exercise Program Using Mobile Technology After Left Ventricular Assist Device Implantation

NCT06291922

RECRUITING Phase 1

TumorGlow Intraoperative Molecular Imaging (IMI)

NCT04723810

RECRUITING

Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children

NCT06529575

RECRUITING Phase 2

Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia

NCT06968663

RECRUITING

Evaluation of Periapical Healing Following Endodontic Microsurgery With Leukocyte and Platelet Rich Fibrin (L-PRF)

NCT06545084

RECRUITING NA

tACS to Enhance Language Abilities

NCT06092814

RECRUITING Phase 2

Sildenafil for Microvasculopathy in Chronic TBI

NCT05782244

RECRUITING NA

An Intervention Mapping Approach to Closing the Gap in Maternal OUD and Infant NAS Care (SUPPORT)

NCT06576323

RECRUITING Phase 3

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia

NCT06408181

← Previous Page 2 of 29 Next →

Phase Distribution

PhaseTrial count
Phase 1 182
Phase 2 157
Phase 3 43
Phase 4 87

What is open in the University of Pennsylvania pipeline

199 recruiting of 1,423 indexed (14% open); 982 completed (69%).

Phase mix: 130 late (III/IV) vs 339 early (I/II) (early-phase heavy).

Top condition: Obesity (17 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.